To validate NF2 as a driver of MEK inhibitor resistance and elucidate functional consequences of combined NF1 and NF2 loss in Schwann cell tumors, NF2 was suppressed in NF1-mutant NF95.11b neurofibroma cells using CRISPRi. Here, NF2 is linked to neurofibroma.